Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme

Journal of Clinical Neuroscience

Volumn 12, Issue 8, 2005, Pages 930-933

  Chang, Cheng Yi ^a   Li, Mu Chun ^a   Liao, Su Lan ^a   Huang, Yen Len ^b   Shen, Chiung Chyi ^a   Pan, Hung Chuan ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Glioblastoma; Interleukin 6; Prognosis

Indexed keywords

CYTOKINE; INTERLEUKIN 6; KI 67 ANTIGEN; MESSENGER RNA; TUMOR MARKER;

AGE DISTRIBUTION; ANGIOGENESIS; ARTICLE; BLOOD VESSEL; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; EDEMA; ENDOTHELIUM CELL; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMAGING; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY CELL; MALIGNANT TRANSFORMATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; SURVIVAL TIME; BIOSYNTHESIS; BRAIN TUMOR; GENE EXPRESSION; METABOLISM; MORTALITY; PATHOLOGY;

BRAIN NEOPLASMS; GENE EXPRESSION; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; KI-67 ANTIGEN; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 28544453276     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2004.11.017     Document Type: Article

References (18)

1. T. Kishimoto The biology of interleukin-6 Blood 74 1989 1 10
2. J.M. Le, and J. Vilcek Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response Lab Invest 61 1989 588 602
3. B.E. Barton IL-6-like cytokines and cancer cachexia: consequences of chronic inflammation Immunol Res 23 2001 41 58
4. S.S. Tabibzadeh, D. Poubouridis, L.T. May, and P.B. Sehgal Interleukin-6 immunoreactivity in human tumors Am J Pathol 135 1989 427 433
5. O. Gallo, D. Bani, G. Toccafondi, F. Almerigogna, and O.F. Storchi Characterization of a novel cell line from pleiomorphic adenoma of the parotid gland with myoepithelial phenotype and producing interleukin-6 as an autocrine growth factor Cancer 70 1992 559 568
6. C. Rolhion, F. Penault-Llorca, and J.L. Kemeny Interleukin-6 overexpression as a marker of malignancy in human gliomas J Neurosurg 94 2001 97 101
7. S. Goswami, A. Gupta, and S.K. Sharma Interleukin-6-mediated autocrine growth promotion in human glioblastoma multiforme cell line U87MG J Neurochem 71 1998 1837 1845
8. A. Tchirkov, C. Rolhion, S. Bertrand, J.F. Dore, J.J. Dubost, and P. Verrelle IL-6 gene amplification and expression in human glioblastoma Br J Cancer 85 2001 518 522
9. R.F. Del Maestro, J.F. Megyesi, and C.L. Farrell Mechanisms of tumor-associated edema: a review Can J Neurol Sci 17 1990 177 183
10. E. Fattori, M. Cappelletti, and P. Costa Defective inflammatory response in interleukin 6-deficient mice J Exp Med 180 1994 1243 1250
11. E. Tarkowski, L. Rosengren, and C. Blomstrand Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke Stroke 26 1995 1393 1398
12. S. Hirohata, and T. Miyamoto Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement Arthritis Rheum 33 1990 644 649
13. T. Takano, M. Ohno, Y. Takeuchi, R. Mandai, and S. Yoshida Cytotoxic edema and interleukin-6 in hypertensive encephalopathy Pediatr Neurol 26 2002 71 73
14. D. Fee, D. Grzybicki, and M. Dobbs Interleukin 6 promotes vasculogenesis of murine brain microvessel endothelial cells Cytokine 12 2000 655 665
15. H. Safdari, F.H. Hochberg, and E.P. Richardson Jr Prognostic value of round cell (lymphocyte) infiltration in malignant gliomas Surg Neurol 23 1985 221 226
16. M.C. Gingras, E. Roussel, J.A. Roth, and R.P. Moser Little expression of cytokine mRNA by fresh tumour-infiltrating mononuclear leukocytes from glioma and lung adenocarcinoma Cytokine 7 1995 580 588
17. J. Lotem, H. Gal, and R. Kama Inhibition of p53-induced apoptosis without affecting expression of p53-regulated genes Proc Natl Acad Sci USA 100 2003 6718 6723
18. K. Akakura, H. Suzuki, and T. Ueda Possible mechanism of dexamethasone therapy for prostate cancer: Suppression of circulating level of interleukin-6 Prostate 56 2003 106 109